A SBIR Phase I contract was awarded to TRANSMURAL SYSTEMS LLC for $397,302.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
The goal of the project is to develop a device for percutaneous closure of postinfarction ventricular septal defectVSDin adultsFirst a prototype would be developed and tested in animalsand ultimately a clinical grade device would undergo regulatory developmentPhase I will include the development and testing of a postinfarction VSD occluder prototypePhase II will include mechanical and safety testing and regulatory development of the device